Gallbladder inflammation, gallstones
Conditions
Interventions
Control group:Physiological saline (same dose)
Experimental group:escalodine, 0.25mg /kg/ h
Sponsors
Shanghai East Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients scheduled for laparoscopic cholecystectomy; 2. ASA classification I-II, aged 18-80 years; 3. Patients are healthy with no other congenital diseases; 4. Patients voluntarily sign the informed consent form; 5. No allergy to the trial medication; 6. Patients receive the trial medication with good compliance.
Exclusion criteria
Exclusion criteria: 1. Patients with severe neuropsychiatric disorders who cannot cooperate; 2. Patients with serious illnesses (heart, lung, brain, kidney, etc.); 3. Patients with recent respiratory infections; 4. Patients allergic to the investigational drug; 5. Participants explicitly refusing to participate in this study; 6. Minors, pregnant women, or those in pregnancy; 7. Patients undergoing non-primary cholecystectomy; 8. Patients with severe .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pittsburgh Sleep Quality Index Score;quality of recovery-40 questionnaire Score;Self-Rating Anxiety Scale Score;Pain threshold; | — |
Countries
China
Contacts
Public ContactQi Shiyuan
Shanghai East Hospital
Outcome results
None listed